Holding(s) in Company

RNS Number : 0624C
GlaxoSmithKline PLC
26 August 2008
 



GlaxoSmithKline plc received on 26 August 2008 from Legal & General Group plc a notification of interests in GlaxoSmithKline plc Ordinary shares of 25 pence each, dated 26 August 2008. This notice is given in accordance with DTR 5.8.12.


TR-1:   notification of major interests in shares 


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

GlaxoSmithKline Plc

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 


 

An event changing the breakdown of voting rights


Other (please specify):______________


3. Full name of person(s) subject to the notification obligation:

Legal & General Group Plc (Group)

Legal & General Investment Management Limited (LGIM)

4. Full name of shareholder(s) (if different from 3.):

Legal & General Assurance (Pensions Management) Limited (PMC)

Legal & General Group Plc (L&G)

5. Date of the transaction (and date on which the threshold is crossed or reached if different):

21 August 2008

6. Date on which issuer notified:

26 August 2008

7. Threshold(s) that is/are crossed or reached:

Above 5% (Group)

Above 5% (LGIM)


8. Notified details:


A: Voting rights attached to shares

Class/type of shares 

 if possible using the ISIN CODE

Situation previous to the Triggering transaction 

Resulting situation after the triggering transaction

Number of Shares 

Number of Voting Rights 

Number of shares 

Number of voting rights

% of voting rights

Direct  

Indirect 

Direct

Indirect

ORD

GBP 0.25

Below 5%

261,984,775

244,172,773

17,812,002

4.6606

0.3399


B: Financial Instruments

Resulting situation after the triggering transaction 

Type of financial instrument 

Expiration date 

Exercise/ Conversion Period/ Date 

Number of voting rights that may be acquired if the instrument is exercised/ converted. 

% of voting rights

   

   

   

   

   


Total (A+B)

Number of voting rights

% of voting rights

261,984,775

5.00


9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

Legal & General Group Plc (Direct and Indirect) (Group) (261,984,775 - 5.00% = Total Position) 


Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect)  (261,984,775 - 5.00% = Total Position)


Legal & General Investment Management Limited (Indirect) (LGIM) (261,984,775 - 5.00% = Total Position)


Legal & General Group Plc (Direct) (L&G) (244,172,773 - 4.66% = LGAS, LGPL & PMC)

Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD) (200,498,767 - 3.82% = PMC)  

Legal & General Insurance Holdings Limited (Direct) (LGIH) 

Legal & General Assurance (Pensions Management) Limited (PMC) (200,498,767 - 3.82% = PMC)  

Legal & General Assurance Society Limited (LGAS & LGPL) 


Legal & General Pensions Limited (Direct)  (LGPL)



Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A


13. Additional information:

Notification using the total voting rights figure of  5,238,275,257 


14. Contact name:

Helen Lewis (LGIM)

15. Contact telephone number:

020 3124 3851



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPFMFTMMMTBMP

Companies

GSK (GSK)
UK 100

Latest directors dealings